Population Pharmacokinetic–Pharmacodynamic Modeling of Granulocyte Colony‐Stimulating Factor to Optimize Dosing and Timing for CD34+ Cell Harvesting
Open Access
- 2 January 2025
- journal article
- research article
- Published by Wiley in Clinical and Translational Science
- Vol. 18 (1) , e70121
Abstract
Granulocyte colony‐stimulating factor (G‐CSF) mobilizes peripheral blood (PB) progenitor cells from bone marrow (BM) into circulation for PB stem cell transplantation (PBSCT). This study aimed to develop a population pharmacokinetic–pharmacodynamic (PK‐PD) model of filgrastim in healthy subjects to optimize PB CD34+ cell collection. Plasma filgrastim concentrations and CD34+ cell count data were obtained from a clinical study involving healthy Korean subjects. A total of 1378 plasma concentration measurements and 982 CD34+ cell count data collected from 53 subjects were used in the PK‐PD model. Filgrastim PKs were adequately described by a one‐compartment linear disposition model with an additional transit compartment for absorption. Log‐transformed body weight was the only significant covariate affecting the volume of distribution and clearance. CD34+ cell mobilization was best captured by a modified Friberg model, assuming continual entry of proliferating BM stem cells into PB via a single transit compartment. Simulation results suggested that the 5 μg/kg twice‐daily dosing regimen may yield higher CD34+ cell counts compared to the 10 μg/kg once‐daily regimen for achieving target CD34+ cell counts of 20/μL and 50/μL. We successfully developed a robust PK‐PD model of G‐CSF that optimizes the yield of CD34+ cells during allogeneic PBSCT. This model can guide the efficient determination of optimal G‐CSF dosing regimens and CD34+ cell harvesting strategies.Keywords
This publication has 49 references indexed in Scilit:
- Kinetics of G–CSF and CD34+ cell mobilization after once or twice daily stimulation with rHu granulocyte‐stimulating factor (lenograstim) in healthy volunteers: an intraindividual crossover studyTransfusion, 2004
- Model of Chemotherapy-Induced Myelosuppression With Parameter Consistency Across DrugsJournal of Clinical Oncology, 2002
- Dose and Schedule Effect of G-GSF for Stem Cell Mobilization in Healthy Donors for Allogeneic TransplantationLeukemia & Lymphoma, 2002
- Estimation of rhG-CSF absorption kinetics after subcutaneous administration using a modified Wagner–Nelson method with a nonlinear elimination modelEuropean Journal of Pharmaceutical Sciences, 2001
- Single vs twice daily G-CSF dose for peripheral blood stem cells harvest in normal donors and children with non-malignant diseasesBone Marrow Transplantation, 2000
- Distribution of Granulocyte Colony-Stimulating Factor (G-CSF) and G-CSF-Receptor mRNA and Protein in the Human FetusPediatric Research, 1999
- G-CSF-induced mobilization of peripheral blood stem cells for allografting: comparative study of daily single versus divided dose of G-CSF.1997
- Clinical pharmacology of filgrastim following high-dose chemotherapy and autologous bone marrow transplantation.1997
- The kinetics of G‐CSF mobilization of CD34+ cells in healthy peopleTransfusion Medicine, 1997
- Optimization of the yield of PBSC for autotransplantation mobilized by high-dose chemotherapy and G-CSF: proposal for a mathematical model.1994